Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12885837

J. Clin. Oncol. 2003 Sep 15 21 18 3402-8

Download in:

View as

General Info

PMID
12885837